Suchergebnisse - "De Maio, Flavio"

PubPharm (7)

1

Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children

enthalten in: European journal of pediatrics | 2023

von Buonsenso, D. | Delogu, G. | Del Carmen Pereyra Boza, M. | +7

2

Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children

enthalten in: European journal of pediatrics | 2023

von Buonsenso, D. | Delogu, G. | del Carmen Pereyra Boza, M. | +7

3

The Dark Side of the COVID-19 Treatments on Mycobacterium Tuberculosis Infection

enthalten in: Mediterranean journal of hematology and infectious diseases | 2022

von De Maio, F. | Bianco, D. | Delogu, G.

4

First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness

enthalten in: International journal of medical microbiology : IJMM | 2021

von De Maio, F. | Cingolani, A. | Bianco, D. | +5

5

IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay

enthalten in: International journal of medical microbiology : IJMM | 2019

von Palucci, I. | Battah, B. | Salustri, A. | +9

6

The Mycobacterial HBHA Protein : A Promising Biomarker for Tuberculosis

enthalten in: Current medicinal chemistry | 2019

von De Maio, F. | Squeglia, F. | Goletti, D. | +1

7

Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children

enthalten in: The Journal of infection | 2018

von Sali, M. | Buonsenso, D. | D'Alfonso, P. | +9

1
[1]